Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
American Journal of Clinical Dermatology
Erschienen in: American Journal of Clinical Dermatology 6/2016

01.12.2016 | Evidence-Based Review

Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review

verfasst von: Brittany L. Vieira, Neil R. Lim, Mary E. Lohman, Peter A. Lio

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Complementary and alternative interventions are becoming increasingly utilized as adjuncts to conventional treatment of atopic dermatitis (AD). While the number of studies continues to grow, the vastness of the subject coupled with the relatively poor quality and small size of the studies limit their usefulness to clinicians.

Purpose

Our aim was to comprehensively review randomized controlled trials (RCTs) of complementary and alternative therapies for AD.

Methods

Searches were performed on PubMed, the Cochrane Central Register of Controlled Trials, EMBASE, and the Global Resource for EczemA Trial (GREAT) databases, focusing on RCTs of alternative or complementary AD therapies, with a sample size of ≥10, through March 2015 and limited to the English language. A total of 70 manuscripts met the inclusion criteria and were included in the final analysis.

Results

There is at least some level I evidence to support the use of acupuncture and acupressure, stress-reducing techniques such as hypnosis, massage, and biofeedback, balneotherapy, herbal preparations (with many important caveats), certain botanical oils, oral evening primrose oil, vitamin D supplementation, and topical vitamin B12. Many other therapies either have sufficient data to suggest that they are ineffective, or simply do not have enough evidence to formulate a verdict.

Conclusions

Careful review of the literature reveals several promising therapies in this domain; such findings may help direct further research that is necessary to bolster clinical recommendations for alternative or complementary treatments of AD.
Literatur
1.
Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Investig Dermatol. 2011;131(1):67–73.CrossRefPubMed
2.
Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70(5):421–4.PubMed
3.
Simpson EL, Basco M, Hanifin J. A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat. 2003;14(3):144–7.
4.
Aguiar Júnior N dos R, Costa IMC. The use of alternative or complementary medicine for children with atopic dermatitis. An Bras Dermatol. 2011;86(1):167–8.
5.
6.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.CrossRefPubMedPubMedCentral
7.
Silverberg JI. Atopic dermatitis: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):149–64.CrossRefPubMed
8.
Che-Yi C, Wen CY, Min-Tsung K, Chiu-Ching H. Acupuncture in haemodialysis patients at the Quchi (LI11) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant. 2005;20(9):1912–5.CrossRefPubMed
9.
Pfab F, Huss-Marp J, Gatti A, et al. Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema—a blinded, randomized, placebo-controlled, crossover trial. Allergy. 2010;65(7):903–10.CrossRefPubMed
10.
Pfab F, Kirchner MT, Huss-Marp J, et al. Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial. Allergy. 2012;67(4):566–73.CrossRefPubMedPubMedCentral
11.
Lee KC, Keyes A, Hensley JR, et al. Effectiveness of acupressure on pruritus and lichenification associated with atopic dermatitis: a pilot trial. Acupunct Med. 2012;30(1):8–11.CrossRefPubMed
12.
Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16:114–22.CrossRefPubMed
13.
Sokel B, Kent CA, Lansdown R, et al. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnosis. 1993;10(3):145–54.
14.
Miller RM, Coger RW. Skin conductance conditioning with dyshidrotic eczema patients. Br J Dermatol. 1979;101(4):435–40.CrossRefPubMed
15.
Schut C. Psychophysiological effects of stress management in patients with atopic dermatitis: a randomized controlled trial. Acta Derm Venereol. 2013;93(1):57–61.PubMed
16.
Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995;63(4):624–35.CrossRefPubMed
17.
Schachner L, Field T, Hernandez-Reif M, Duarte AM, Krasnegor J. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatric dermatology. 1998;15(5):390–95.
18.
Bae BG, Oh SH, Park CO, et al. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Acta Derm Venereol. 2012;92(1):57–61.CrossRefPubMed
19.
Anderson C, Lis-Balchin M, Kirk-Smith M. Evaluation of massage with essential oils on childhood atopic eczema. Phytother Res PTR. 2000;14(6):452–6.CrossRefPubMed
20.
Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136(5):1170–7.CrossRefPubMed
21.
22.
McNally NJ, Williams HC, Phillips DR, et al. Atopic eczema and domestic water hardness. Lancet. 1998;352(9127):527–31.CrossRefPubMed
23.
Thomas KS, Koller K, Dean T, et al. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess (Winchester, England). 2011;15(8):v–vi, 1–156.
24.
Togawa Y. Ultrapure soft water improves the skin barrier function of child atopic dermatitis: the first report. J Investig Dermatol. 2012;132:S68.
25.
Heinlin J, Schiffner-Rohe J, Schiffner R, et al. A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow-band UVB monotherapy for atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2011;25(7):765–73.CrossRefPubMed
26.
Farina S, Gisondi P, Zanoni M, et al. Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. J Dermatol Treat. 2011;22(6):366–71.CrossRef
27.
Zhang GG, Lee W, Bausell B, et al. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. J Altern Complement Med. 2005;11(3):415–21.CrossRefPubMed
28.
Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med. 2015;2015:316706.PubMedPubMedCentral
29.
30.
Cheng HM, Chiang LC, Jan YM, et al. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2011;155(2):141–8.CrossRefPubMed
31.
Choi IH, Kim S, Kim Y, Yun Y. The effect of TJ-15 plus TJ-17 on atopic dermatitis: a pilot study based on the principle of pattern identification. J Altern Complemen Med (New York, N.Y.). 2012;18(6):576–82.
32.
Xq X, Cheng S, Ma H, et al. Combination of flying needle with Chinese herbal medicine in the treatment of atopic dermatitis: a clinical trial. Pak J Pharm Sci. 2014;27(5 Suppl):1687–90.
33.
Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol. 1992;126:179–84.CrossRefPubMed
34.
Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992;340(8810):13–7.CrossRefPubMed
35.
Fung AY, Look PC, Chong LY, et al. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol. 1999;38(5):387–92.CrossRefPubMed
36.
Henderson CA, Morris A, Wilson A, Ilchyshyn A. An open study comparing the efficacy of two different Chinese herbal therapy formulations in atopic eczema and their effects on circulating activated T-lymphocytes. J Dermatol Treat. 2000;11(2):91–96.
37.
Kobayashi H, Ishii M, Takeuchi S, et al. Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of Kikyo (Delicate Constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Altern Med. 2010;7(3):367–73.
38.
Hon KL, Leung TF, Ng PC, et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double-blind, placebo-controlled study. Hong Kong Med J = Xianggang yi xue za zhi/Hong Kong Academy of Medicine. 2011;17(Suppl 2):38–40.
39.
Shapira MY, Raphaelovich Y, Gilad L, et al. Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: a double blind, placebo-controlled, randomized trial. J Am Acad Dermatol. 2005;52:691–3.
40.
Winkelmann RR, Del Rosso J, Rigel DS. Polypodium leucotomos extract: a status report on clinical efficacy and safety. J Drugs Dermatol. 2015;14(3):254–61.PubMed
41.
Ramirez-Bosca A, Zapater P, Betlloch I, et al. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial. Actas Dermosifiliogr. 2012;103(7):599–607.CrossRefPubMed
42.
Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. John’s wort cream–a randomized, placebo controlled, double blind half-side comparison. Phytomedicine. 2003;10(Suppl 4):31–7.CrossRefPubMed
43.
Patzelt-Wenczler R, Ponce-Poschl E. Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res. 2000;5(4):171–5.PubMed
44.
Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat. 2003;14(3):153–7.CrossRef
45.
Klovekorn W, Tepe A, Danesch U. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis. Int J Clin Pharmacol Ther. 2007;45(11):583–91.CrossRefPubMed
46.
Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26(6):669–75.CrossRefPubMed
47.
De Belilovsky C, Roo-Rodriguez E, Baudouin C, et al. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatol Treat. 2011;22(6):359–65.CrossRef
48.
Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol. 2013;30(1):42–50.CrossRefPubMed
49.
Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892–1908.
50.
Lio PA, Lee M, LeBovidge J, et al. Clinical management of atopic dermatitis: practical highlights and updates from the atopic dermatitis practice parameter 2012. J Allergy Clin Immunol Pract. 2014;2(4):361–9.
51.
Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401.CrossRefPubMedPubMedCentral
52.
Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis. 2008;19(6):308–15.
53.
Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100–8.CrossRefPubMed
54.
Lee J, Bielory L. Complementary and alternative interventions in atopic dermatitis. Immunol Allergy Clin N Am. 2010;30(3):411–24.CrossRef
55.
Anstey A, Quigley M, Wilkinson JD. Topical evening primrose oil as treatment for atopic eczema. J Dermatol Treat. 1990;1(4):199–201.
56.
Ferreira MJ, Fiadeiro T, Silva M, Soares AP. Topical-linolenic acid therapy in atopic dermatitis. A clinical and biometric evaluation. Allergo J. 1998;7(4):213–16.
57.
Kanehara S, Ohtani T, Uede K, Furukawa F. Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: a double-blind, placebo-controlled clinical trial. J Dermatol. 2007;34(12):811–5.CrossRefPubMed
58.
Korting HC, Schollmann C, Cholcha W, Wolff L. Efficacy and tolerability of pale sulfonated shale oil cream 4 % in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial. J Eur Acad Dermatol Venereol. 2010;24(10):1176–82.CrossRefPubMed
59.
Brown WR, Hansen AE. Arachidonic and linoleic acid of the serum in normal and eczematous human subjects. Proc Soc Exp Biol Med. 1937;36:113–7.
60.
Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;4:CD004416.
61.
Henz BM, Jablonska S, van de Kerkhof PC, et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 1999;140(4):685–8.CrossRefPubMed
62.
Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ (Clinical research ed.). 2003;327(7428):1385.
63.
Valsecchi R, Di Landro A, Pansera B, Reseghetti A. Gammalinolenic acid in the treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 1996;7(1):77–9.CrossRef
64.
Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res. 1988;14(4):291–7.PubMed
65.
Schalin-Karrila M, Mattila L, Jansen CT, et al. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br J Dermatol. 1987;117 (1):11–19.
66.
Humphreys F, Symons JA, Brown HK, et al. The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur J Dermatol. 1994;4 (8):598–603.
67.
Senapati S, Banerjee S, Gangopadhyay DN. Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2008;74(5):447–52.CrossRefPubMed
68.
Bamford JT, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol. 1985;13(6):959–65.CrossRefPubMed
69.
Williams HC. Evening primrose oil for atopic dermatitis. BMJ. 2003;327(7428):1258–9.CrossRef
70.
Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 1993;341(8860):1557–60.CrossRefPubMed
71.
Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res. 1994;20(2):77–84.PubMed
72.
Chung B. Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis. Ann Dermatol. 2013;25(3):285–91.
73.
Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet. 1982;2(8308):1120–2.CrossRefPubMed
74.
Mayser P, Mayer K, Mahloudjian M, et al. A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. JPEN J Parenter Enteral Nutr. 2002;26(3):151–8.CrossRefPubMed
75.
Bjorneboe A, Soyland E, Bjorneboe GE, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol. 1987;117(4):463–9.CrossRefPubMed
76.
Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 1994;130(6):757–64.CrossRefPubMed
77.
Callaway J, Schwab U, Harvima I, et al. Efficacy of dietary hempseed oil in patients with atopic dermatitis. J Dermatol Treat. 2005;16(2):87–94.CrossRef
78.
Koch C, Dolle S, Metzger M, et al. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br J Dermatol. 2008;158(4):786–92.CrossRefPubMed
79.
Gimenez-Arnau A, Barranco C, Alberola M, et al. Effects of linoleic acid supplements on atopic dermatitis. Adv Exp Med Biol. 1997;433:285–9.CrossRefPubMed
80.
Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev. 2012;2:CD005205.
81.
Mabin DC, Hollis S, Lockwood J, David TJ. Pyridoxine in atopic dermatitis. Br J Dermatol. 1995;133(5):764–7.CrossRefPubMed
82.
Fairris GM, Perkins PJ, Lloyd B, Hinks L, Clayton BE. The effect on atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venereol. 1989;69(4):359–62.PubMed
83.
Ewing CI, Gibbs AC, Ashcroft C, David TJ. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr. 1991;45(10):507–10.PubMed
84.
85.
Amestejani M, Salehi BS, Vasigh M, et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol JDD. 2012;11(3):327–30.PubMed
86.
Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134(4):831–835.e831.
87.
Hata TR, Audish D, Kotol P, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2014;28(6):781–9.CrossRefPubMed
88.
Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245–7.CrossRefPubMed
89.
Javanbakht MH, Keshavarz SA, Djalali M, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatol Treat. 2011;22(3):144–50.CrossRef
90.
Faghihi G, Iraji F, Shahingohar A, Saidat A. The efficacy of ‘0.05 % clobetasol + 2.5 % zinc sulphate’ cream vs. ‘0.05 % clobetasol alone’ cream in the treatment of the chronic hand eczema: a double-blind study. J Eur Acad Dermatol Venereol JEADV. 2008;22(5):531–6.CrossRefPubMed
91.
Januchowski R. Evaluation of topical vitamin B(12) for the treatment of childhood eczema. J Altern Complement Med (New York, N.Y.). 2009;15(4):387–89.
92.
Stucker M, Pieck C, Stoerb C, et al. Topical vitamin B12–a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial. Br J Dermatol. 2004;150(5):977–83.CrossRefPubMed
93.
D’Aurizio F, Villalta D, Metus P, et al. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid disease? Autoimmun Rev. 2015;14(5):363–9.CrossRefPubMed
94.
Schoni MH, Nikolaizik WH, Schoni-Affolter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol. 1997;112(3):238–46.CrossRefPubMed
95.
Tripodi S, Di Rienzo Businco A, Panetta V, et al. Lack of efficacy of topical furfuryl palmitate in pediatric atopic dermatitis: a randomized double-blind study. J Investig Allergol Clin Immunol. 2009;19(3):204–209.
96.
Kwon H. Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study. J Dermatol. 2013;40(3):207–10.CrossRefPubMed
97.
Vita D, Passalacqua G, Di Pasquale G, et al. Ass’s milk in children with atopic dermatitis and cow’s milk allergy: crossover comparison with goat’s milk. Pediatr Allergy Immunol. 2007;18(7):594–8.CrossRefPubMed
Metadaten
Titel
Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review
verfasst von
Brittany L. Vieira
Neil R. Lim
Mary E. Lohman
Peter A. Lio
Publikationsdatum
01.12.2016
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 6/2016
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0209-1

Weitere Artikel der Ausgabe 6/2016

American Journal of Clinical Dermatology 6/2016 Zur Ausgabe

Original Research Article

Nationwide Assessment of Cause-Specific Mortality in Patients with Rosacea: A Cohort Study in Denmark

Review Article

Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress

Original Research Article

Itch in the General Internal Medicine Setting: A Cross-Sectional Study of Prevalence and Quality-of-Life Effects

Review Article

Primary and Secondary Chemoprevention of Malignant Melanoma

Therapy in Practice

Medical Malpractice in Dermatology—Part II: What To Do Once You Have Been Served with a Lawsuit

Review Article

Exercise-Induced Vasculitis: A Review with Illustrated Cases

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise